276 related articles for article (PubMed ID: 17703497)
1. Modulation of scratching behavior by silencing an endogenous cyclooxygenase-1 gene in the skin through the administration of siRNA.
Inoue T; Sugimoto M; Sakurai T; Saito R; Futaki N; Hashimoto Y; Honma Y; Arai I; Nakaike S
J Gene Med; 2007 Nov; 9(11):994-1001. PubMed ID: 17703497
[TBL] [Abstract][Full Text] [Related]
2. COX-1 inhibition enhances scratching behaviour in NC/Nga mice with atopic dermatitis.
Sugimoto M; Arai I; Futaki N; Hashimoto Y; Honma Y; Nakaike S
Exp Dermatol; 2006 Aug; 15(8):582-8. PubMed ID: 16842596
[TBL] [Abstract][Full Text] [Related]
3. Effect of siRNA nuclease stability on the in vitro and in vivo kinetics of siRNA-mediated gene silencing.
Bartlett DW; Davis ME
Biotechnol Bioeng; 2007 Jul; 97(4):909-21. PubMed ID: 17154307
[TBL] [Abstract][Full Text] [Related]
4. In vivo gene silencing in solid tumors by targeted electrically mediated siRNA delivery.
Golzio M; Mazzolini L; Ledoux A; Paganin A; Izard M; Hellaudais L; Bieth A; Pillaire MJ; Cazaux C; Hoffmann JS; Couderc B; Teissié J
Gene Ther; 2007 May; 14(9):752-9. PubMed ID: 17344906
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of gene expression in mice muscle by in vivo electrically mediated siRNA delivery.
Golzio M; Mazzolini L; Moller P; Rols MP; Teissié J
Gene Ther; 2005 Feb; 12(3):246-51. PubMed ID: 15592423
[TBL] [Abstract][Full Text] [Related]
6. Involvement of IL-31 on scratching behavior in NC/Nga mice with atopic-like dermatitis.
Takaoka A; Arai I; Sugimoto M; Honma Y; Futaki N; Nakamura A; Nakaike S
Exp Dermatol; 2006 Mar; 15(3):161-7. PubMed ID: 16480423
[TBL] [Abstract][Full Text] [Related]
7. Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity.
Akhtar S; Benter I
Adv Drug Deliv Rev; 2007 Mar; 59(2-3):164-82. PubMed ID: 17481774
[TBL] [Abstract][Full Text] [Related]
8. Time course changes of scratching counts, dermatitis symptoms, and levels of cutaneous prostaglandins in NC/Nga mice.
Sugimoto M; Arai I; Futaki N; Hashimoto Y; Sakurai T; Honma Y; Nakaike S
Exp Dermatol; 2006 Nov; 15(11):875-82. PubMed ID: 17002684
[TBL] [Abstract][Full Text] [Related]
9. Exploring RNA interference as a therapeutic strategy for renal disease.
Takabatake Y; Isaka Y; Mizui M; Kawachi H; Shimizu F; Ito T; Hori M; Imai E
Gene Ther; 2005 Jun; 12(12):965-73. PubMed ID: 15729369
[TBL] [Abstract][Full Text] [Related]
10. Role of scratch-induced cutaneous prostaglandin D production on atopic-like scratching behaviour in mice.
Takaoka A; Arai I; Sugimoto M; Futaki N; Sakurai T; Honma Y; Nakaike S
Exp Dermatol; 2007 Apr; 16(4):331-9. PubMed ID: 17359340
[TBL] [Abstract][Full Text] [Related]
11. Oral administration of bepotastine besilate suppressed scratching behavior of atopic dermatitis model NC/Nga mice.
Tanizaki H; Kambe N; Nakamura Y; Tanaka A; Matsuda H; Miyachi Y
Int Arch Allergy Immunol; 2008; 145(4):277-82. PubMed ID: 18004068
[TBL] [Abstract][Full Text] [Related]
12. Increased scratching counts depend on a decrease in ability of cutaneous prostaglandin D2 biosynthesis in NC/Nga mice with atopic dermatitis.
Sugimoto M; Arai I; Futaki N; Hashimoto Y; Honma Y; Nakaike S
Exp Dermatol; 2005 Dec; 14(12):898-905. PubMed ID: 16274457
[TBL] [Abstract][Full Text] [Related]
13. Small interfering RNA (siRNA) delivery into monocyte-derived dendritic cells by electroporation.
Prechtel AT; Turza NM; Theodoridis AA; Kummer M; Steinkasserer A
J Immunol Methods; 2006 Apr; 311(1-2):139-52. PubMed ID: 16556448
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic effects on atopic dermatitis by anti-RelA short interfering RNA combined with functional peptides Tat and AT1002.
Uchida T; Kanazawa T; Kawai M; Takashima Y; Okada H
J Pharmacol Exp Ther; 2011 Aug; 338(2):443-50. PubMed ID: 21531792
[TBL] [Abstract][Full Text] [Related]
15. A method to induce stable atopic dermatitis-like symptoms in NC/Nga mice housed with skin-lesioned mice.
Takano N; Arai I; Kurachi M
Br J Dermatol; 2006 Mar; 154(3):426-30. PubMed ID: 16445770
[TBL] [Abstract][Full Text] [Related]
16. RNA interference in the mouse vascular endothelium by systemic administration of siRNA-lipoplexes for cancer therapy.
Santel A; Aleku M; Keil O; Endruschat J; Esche V; Durieux B; Löffler K; Fechtner M; Röhl T; Fisch G; Dames S; Arnold W; Giese K; Klippel A; Kaufmann J
Gene Ther; 2006 Sep; 13(18):1360-70. PubMed ID: 16625242
[TBL] [Abstract][Full Text] [Related]
17. Transfer of small interfering RNA by single-cell electroporation in cerebellar cell cultures.
Tanaka M; Yanagawa Y; Hirashima N
J Neurosci Methods; 2009 Mar; 178(1):80-6. PubMed ID: 19114056
[TBL] [Abstract][Full Text] [Related]
18. Prostanoid DP1 receptor agonist inhibits the pruritic activity in NC/Nga mice with atopic dermatitis.
Arai I; Takano N; Hashimoto Y; Futaki N; Sugimoto M; Takahashi N; Inoue T; Nakaike S
Eur J Pharmacol; 2004 Nov; 505(1-3):229-35. PubMed ID: 15556157
[TBL] [Abstract][Full Text] [Related]
19. Expression of IL-31 gene transcripts in NC/Nga mice with atopic dermatitis.
Takaoka A; Arai I; Sugimoto M; Yamaguchi A; Tanaka M; Nakaike S
Eur J Pharmacol; 2005 Jun; 516(2):180-1. PubMed ID: 15925362
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic potential of RNA interference against cancer.
Takeshita F; Ochiya T
Cancer Sci; 2006 Aug; 97(8):689-96. PubMed ID: 16863503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
